On 16 December, the DHSC announced that the 2025 headline VPAG repayment percentage for sales of “newer medicines” will be 22.9%. This...

The consultation on the future of the UK’s Medical Devices Regulations 2002 (UK MDR), initiated by the MHRA on 14 November 2024,...

Background The MHRA has launched a Consultation on future changes to the UK Medical Devices Regulations. The consultation addresses four...

We had an insightful day hearing about the future of UK life sciences regulation at the BIA’s flagship annual Life Sciences Regulatory...

The MHRA has provided more information on its plans for rolling-out its new medical device framework. It aims to publish its additional...

This article was first published in Kluwer Patent Blog [October 2024]. On 8 October 2024, Mr Justice Meade handed down judgment in...

Back in July I speculated, based on the King's Speech, that the new government's proposals for scientific research were likely to be a...

On 25 September 2024, the MHRA updated its roll-out of the new medical device regulatory framework for Great Britain. The MHRA aims to...

TEAM-NB has published a new version (v5.0) of its Code of Conduct for Notified Bodies. While we don’t normally comment on this Code,...

This article was first published in Kluwer Blog [August, 2024]. Background In June 2024, we reported that in an application for...

Vertex Pharmaceuticals announced a reimbursement agreement with NHS England for individuals 12 years or older with transfusion-dependent...

This article was first published in EPLAW blog [August, 2024]. Patents Court finds Janssen Biotech’s patent, for the antibody ustekinumab...